MedBridge Shanghai · International medical facilitation platform recognized under Shanghai Government Document No. 32
Back to home
Boao Super Hospital (Boao Lecheng International Medical Tourism Pilot Zone)

National medical special zone · Licensed early access to global drugs & devices

Boao Super Hospital (Boao Lecheng International Medical Tourism Pilot Zone)

Lung cancerBreast cancerLymphomaLeukemiaColorectal cancer

Established

2018

Beds

500+

Annual Volume

20,000+

Boao, Hainan

Under national licensed-care policies, cancer patients can access the latest oncology drugs and devices approved overseas but not yet in mainland China, with Hainan’s visa-free entry.

About the Hospital

Boao Super Hospital is located in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan. Under national special-access policies, it can use innovative drugs and devices approved overseas but not yet in mainland China — a key bridge between patients in China and global novel therapies.

The hospital operates under a “1+X” model jointly run by multiple academician teams across oncology, rare diseases and ophthalmology; special-access approvals are fast (usually a few working days), with real-world-data research pathways.

Hospital Strengths

01The special-access drug and device channel

The only zone in mainland China where overseas-approved but not-yet-domestically-approved innovative drugs and devices can be legally used, covering hundreds of oncology, immunology and rare-disease products.

02An academician co-building model

Specialty teams led by multiple academicians are based here, offering one-stop access to top experts and special-access medication.

03A real-world research platform

Special-access usage data feed real-world research, accelerating some products toward full approval in China.

Key Departments

Cancer CenterRare Disease CenterInternational Medical DepartmentPharmacy (Special Access)

Coordinated Treatment Directions

  1. 01Special access to overseas innovative oncology drugs
  2. 02Special-access therapy for rare diseases
  3. 03Real-world research on special-access products
  4. 04International medical tourism and health management

Officially Reported Treatment Milestones

Early-access clinical application of international innovative drugs and devices

2019–

Leveraging the Boao Lecheng pilot-zone policy and its “1+X” platform model, it has delivered multiple first-in-China clinical applications of international innovative drugs and devices in oncology.

Accreditations & Platforms

  • Core platform of the State Council-approved international medical tourism pilot zone
  • Pilot site for licensed import of urgently needed drugs & devices